A wireless subretinal photovoltaic implant paired with augmented-reality glasses has enabled patients with complete central vision loss from geographic atrophy to read letters, numbers and words, according to results from a European clinical trial published in The New England Journal of Medicine on 20 October 2025.
Medical device manufacturer Owen Mumford has expanded its EcoSafe 1ml safety syringe platform with a companion reusable autoinjector, creating an integrated drug delivery system designed to improve patient accessibility whilst reducing environmental impact.
Giles AI has announced the commercial launch of giles, an AI specialised research agent designed to accelerate healthcare, clinical, and medical research through rapid literature review and data analysis. The tool extracts, analyses, summarises, and references information from verified medical databases and private files, completing tasks within seconds that traditionally require hours of manual work.
A German medical technology company has become the first to receive regulatory approval for artificial intelligence to function as an independent second reader in breast cancer screening and diagnostic mammography across Europe.
An international research team has mapped distinct molecular “fingerprints” in blood proteins across 59 diseases, creating a comprehensive resource that could revolutionise how clinicians distinguish between different conditions and identify early warning signs of illness.
Researchers have developed a pioneering 3D bioceramic scaffold embedded with silver-gallium liquid metal nanoparticles that simultaneously prevents bacterial infections and promotes bone regeneration. The breakthrough technology offers a non-antibiotic solution to one of orthopaedic surgery’s most persistent challenges, with potential to transform outcomes for high-risk patients.
Konan Medical USA has secured CE marking under the European Medical Device Regulation for its objectiveFIELD Analyzer (OFA), enabling distribution across the European Union. The device represents the first FDA 510(k)-cleared objective perimeter that assesses visual field abnormalities through pupillary response measurement rather than subjective patient input
Scientists at the University of Cambridge have created three-dimensional embryo-like structures that produce blood stem cells through a naturally occurring developmental process, eliminating the need for supplementary growth factors. The innovation, termed ‘hematoids’, mimics human embryonic blood development and could transform approaches to regenerative medicine and disease modelling.
A comprehensive analysis of 204 countries reveals life expectancy gains of more than 20 years since 1950, yet adolescents and young adults face rising mortality in North America, Latin America, and sub-Saharan Africa. Non-communicable diseases now account for nearly two-thirds of global health burden.
Cambridge-based digital medicine company electronRx has announced the launch of pDx, a medical-grade application designed to enable remote monitoring of chronic respiratory diseases through smartphone, laptop, or tablet devices. The technology will debut at HLTH 2025 in Las Vegas (19–22 October), offering clinicians new capabilities for assessing cardiopulmonary function without requiring in-person consultations.
April 2024
Tramstraat 15
5611CM Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.